Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy produ...
Q2 2026
Aug 14, 2026
Q1 2026
May 14, 2026
FY 2025
Mar 27, 2026
Q4 2025
Q3 2025
Nov 12, 2025
